HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...

Digital physical therapy company Hinge Health went public last week, raising $437 million and ending an IPO drought for ...

A patient in a Rocket Pharmaceuticals gene therapy trial for a rare heart condition has died, the company said.

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

As a public health official, Jay K. Varma has handled putative anthrax attacks. He says an AI-simulated bioterror attack ...

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

The National Academies of Sciences, Engineering, and Medicine is preparing for a major reorganization as it tries to reduce ...

Harvard's Scott Delaney helped build a database of NIH grant terminations that is being used in litigation against the Trump ...

The human organism is far too complex and unpredictable to program like a computer and optimize for longevity.

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money ...

Earlier gatherings focused on gaining public acceptance for what scientists want to do with CRISPR. This meeting flipped that ...

As the standoff between Harvard and the Trump administration escalates, the university's appeal, and its standing on the ...